# Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

> **NCT02479997** · PHASE2 · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 130 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Indocyanine green
- **DRUG:** Radioisotope

## Key facts

- **NCT ID:** NCT02479997
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-31
- **Primary completion:** 2018-03-08
- **Final completion:** 2018-03-27
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02479997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02479997, "Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02479997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*